HomeCompareMXDHF vs FCPT

MXDHF vs FCPT: Dividend Comparison 2026

MXDHF yields 800.00% · FCPT yields 6.05%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MXDHF wins by $2773896.42M in total portfolio value
10 years
MXDHF
MXDHF
● Live price
800.00%
Share price
$0.25
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2773896.46M
Annual income
$2,226,430,694,490.38
Full MXDHF calculator →
FCPT
FCPT
● Live price
6.05%
Share price
$23.65
Annual div
$1.43
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.1K
Annual income
$5,775.28
Full FCPT calculator →

Portfolio growth — MXDHF vs FCPT

📍 MXDHF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMXDHFFCPT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MXDHF + FCPT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MXDHF pays
FCPT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MXDHF
Annual income on $10K today (after 15% tax)
$68,000.00/yr
After 10yr DRIP, annual income (after tax)
$1,892,466,090,316.82/yr
FCPT
Annual income on $10K today (after 15% tax)
$514.49/yr
After 10yr DRIP, annual income (after tax)
$4,908.99/yr
At 15% tax rate, MXDHF beats the other by $1,892,466,085,407.83/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MXDHF + FCPT for your $10,000?

MXDHF: 50%FCPT: 50%
100% FCPT50/50100% MXDHF
Portfolio after 10yr
$1386948.26M
Annual income
$1,113,215,350,132.83/yr
Blended yield
80.26%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on FCPT right now

MXDHF
Analyst Ratings
2
Buy
Consensus: Buy
Altman Z
-3.4
Piotroski
4/9
FCPT
Analyst Ratings
5
Buy
10
Hold
Consensus: Hold
Price Target
$27.00
+14.2% upside vs current
Range: $25.00 — $29.00
Altman Z
1.4
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MXDHF buys
0
FCPT buys
0
No recent congressional trades found for MXDHF or FCPT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMXDHFFCPT
Forward yield800.00%6.05%
Annual dividend / share$2.00$1.43
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$2773896.46M$49.1K
Annual income after 10y$2,226,430,694,490.38$5,775.28
Total dividends collected$2730603.49M$24.1K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyHold

Year-by-year: MXDHF vs FCPT ($10,000, DRIP)

YearMXDHF PortfolioMXDHF Income/yrFCPT PortfolioFCPT Income/yrGap
1← crossover$90,700$80,000.00$11,401$700.92+$79.3KMXDHF
2$775,180$678,130.84$13,064$864.84+$762.1KMXDHF
3$6,246,019$5,416,576.76$15,051$1,072.48+$6.23MMXDHF
4$47,472,138$40,788,897.61$17,442$1,337.22+$47.45MMXDHF
5$340,525,323$289,730,135.14$20,340$1,677.08+$340.50MMXDHF
6$2,306,680,888$1,942,318,792.24$23,880$2,116.57+$2306.66MMXDHF
7$14,764,459,529$12,296,310,979.28$28,241$2,689.36+$14764.43MMXDHF
8$89,354,478,583$73,556,506,887.09$33,660$3,442.07+$89354.44MMXDHF
9$511,650,252,638$416,040,960,553.41$40,456$4,439.95+$511650.21MMXDHF
10$2,773,896,464,813$2,226,430,694,490.38$49,063$5,775.28+$2773896.42MMXDHF

MXDHF vs FCPT: Complete Analysis 2026

MXDHFStock

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, the Netherlands, Belgium, Spain, Poland, Italy, rest of European Union, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.

Full MXDHF Calculator →

FCPTREIT

FCPT, headquartered in Mill Valley, CA, is a real estate investment trust primarily engaged in the acquisition and leasing of restaurant properties. The Company seeks to grow its portfolio by acquiring additional real estate to lease, on a net basis, for use in the restaurant and retail industries.

Full FCPT Calculator →
📬

Get this MXDHF vs FCPT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MXDHF vs SCHDMXDHF vs JEPIMXDHF vs OMXDHF vs KOMXDHF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.